# PennyMac Mortgage Investment Trust: financial statements, quarterly

PMT · NYSE · CIK 1464423 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pmt.md) · [Financials](/companies/pmt/financials.md) · [Filings](/companies/pmt/filings.md) · [Insiders](/companies/pmt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pmt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [163](/filings/0000950170-24-118949.md) | [84.8 d](/filings/0001193125-26-057041.md) | [74.2](/filings/0000950170-25-061012.md) | [71.2](/filings/0000950170-25-100375.md) | [80.9](/filings/0001193125-25-256280.md) | [108 d](/filings/0001193125-26-057041.md) | [44.5](/filings/0001193125-26-206572.md) | [70.2](/filings/0001193125-26-333089.md) | [99.2](/filings/0001193125-25-256280.md) | [93.6 d](/filings/0001193125-26-057041.md) | [82.1](/filings/0001193125-26-206572.md) | [72.7](/filings/0001193125-26-333089.md) |
| Interest expense | $m | [184](/filings/0000950170-23-057449.md) | [186 d](/filings/0000950170-24-018760.md) | [172](/filings/0000950170-24-052125.md) | [172](/filings/0000950170-24-089255.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [57.0](/filings/0000950170-24-118949.md) | [(12.6) d](/filings/0001193125-26-057041.md) | [(15.2)](/filings/0000950170-25-061012.md) | [3.2](/filings/0000950170-25-100375.md) | [(14.9)](/filings/0001193125-25-256280.md) | [8.6 d](/filings/0001193125-26-057041.md) | [(16.0)](/filings/0001193125-26-206572.md) | [9.5](/filings/0001193125-26-333089.md) | [(11.3)](/filings/0001193125-25-256280.md) | [(16.2) d](/filings/0001193125-26-057041.md) | [2.3](/filings/0001193125-26-206572.md) | [(14.1)](/filings/0001193125-26-333089.md) |
| Net income | $m | [61.4](/filings/0000950170-24-118949.md) | [52.9 d](/filings/0001193125-26-057041.md) | [47.6](/filings/0000950170-25-061012.md) | [25.4](/filings/0000950170-25-100375.md) | [41.4](/filings/0001193125-25-256280.md) | [46.5 d](/filings/0001193125-26-057041.md) | [9.7](/filings/0001193125-26-206572.md) | [7.5](/filings/0001193125-26-333089.md) | [58.3](/filings/0001193125-25-256280.md) | [52.4 d](/filings/0001193125-26-057041.md) | [24.6](/filings/0001193125-26-206572.md) | [30.9](/filings/0001193125-26-333089.md) |
| Diluted EPS | $ per share | [0.51](/filings/0000950170-24-118949.md) | not reported | [0.39](/filings/0000950170-25-061012.md) | [0.17](/filings/0000950170-25-100375.md) | [0.36](/filings/0001193125-25-256280.md) | not reported | [(0.01)](/filings/0001193125-26-206572.md) | [(0.04)](/filings/0001193125-26-333089.md) | [0.55](/filings/0001193125-25-256280.md) | not reported | [0.16](/filings/0001193125-26-206572.md) | [0.23](/filings/0001193125-26-333089.md) |
| Basic EPS | $ per share | [0.59](/filings/0000950170-24-118949.md) | not reported | [0.43](/filings/0000950170-25-061012.md) | [0.17](/filings/0000950170-25-100375.md) | [0.36](/filings/0001193125-25-256280.md) | not reported | [(0.01)](/filings/0001193125-26-206572.md) | [(0.04)](/filings/0001193125-26-333089.md) | [0.55](/filings/0001193125-25-256280.md) | not reported | [0.16](/filings/0001193125-26-206572.md) | [0.23](/filings/0001193125-26-333089.md) |

- Revenue: us-gaap:RevenuesNetOfInterestExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2027-12-31) | period not labelled (2028-03-31) | period not labelled (2028-06-30) | period not labelled (2028-09-30) | period not labelled (2028-12-31) | period not labelled (2029-03-31) | period not labelled (2029-06-30) | period not labelled (2029-09-30) | period not labelled (2029-12-31) | period not labelled (2030-03-31) | period not labelled (2030-06-30) | period not labelled (2030-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $m | [305](/filings/0000950170-24-018760.md) | [305](/filings/0000950170-24-052125.md) | [725](/filings/0000950170-24-089255.md) | [934](/filings/0000950170-24-118949.md) | [424](/filings/0000950170-24-018760.md) | [424](/filings/0000950170-24-052125.md) | [270](/filings/0000950170-24-089255.md) | [217](/filings/0000950170-24-118949.md) | [1,623](/filings/0000950170-24-018760.md) | [1,601](/filings/0000950170-24-052125.md) | [1,586](/filings/0000950170-24-089255.md) | [1,563](/filings/0000950170-24-118949.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Cash and equivalents: not reported
- Total assets: not reported
- Total liabilities: not reported
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: not reported
- Shareholders' equity: not reported

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [63.6 d](/filings/0000950170-24-118949.md) | [533 d](/filings/0001193125-26-057041.md) | [(342)](/filings/0000950170-25-061012.md) | [244 d](/filings/0000950170-25-100375.md) | [(984) d](/filings/0001193125-25-256280.md) | [(1,621) d](/filings/0001193125-26-057041.md) | [(594)](/filings/0001193125-26-206572.md) | [(2,016) d](/filings/0001193125-26-333089.md) | [(1,298) d](/filings/0001193125-25-256280.md) | [(3,306) d](/filings/0001193125-26-057041.md) | [(2,529)](/filings/0001193125-26-206572.md) | [(2,939) d](/filings/0001193125-26-333089.md) |
| Dividends paid | $m | [34.8 d](/filings/0000950170-24-118949.md) | [34.8 d](/filings/0001193125-26-057041.md) | [34.8](/filings/0000950170-25-061012.md) | [34.8 d](/filings/0000950170-25-100375.md) | [34.9 d](/filings/0001193125-25-256280.md) | [34.9 d](/filings/0001193125-26-057041.md) | [34.8](/filings/0001193125-26-206572.md) | [34.8 d](/filings/0001193125-26-333089.md) | [34.8 d](/filings/0001193125-25-256280.md) | [34.8 d](/filings/0001193125-26-057041.md) | [34.8](/filings/0001193125-26-206572.md) | [34.9 d](/filings/0001193125-26-333089.md) |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-118949.md) | [1.5 d](/filings/0001193125-26-057041.md) | [0.0](/filings/0000950170-24-052125.md) | [0.0 d](/filings/0000950170-24-089255.md) | [0.0 d](/filings/0000950170-24-118949.md) | [0.0 d](/filings/0001193125-26-057041.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [90.6](/filings/0000950170-23-057449.md) | [113](/filings/0000950170-24-052125.md) | [87.3](/filings/0000950170-24-089255.md) | [111](/filings/0000950170-24-118949.md) | [111](/filings/0000950170-25-061012.md) | [86.8](/filings/0000950170-25-100375.md) | [86.9](/filings/0001193125-25-256280.md) | [86.9](/filings/0001193125-26-206572.md) | [87.0](/filings/0001193125-26-333089.md) | [87.0](/filings/0001193125-25-256280.md) | [87.1](/filings/0001193125-26-206572.md) | [87.3](/filings/0001193125-26-333089.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 87,202,362 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001193125-26-333089.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.